ATROPHIC VULVOVAGINITIS

This adverse event was reported 731 times

ATROPHIC VULVOVAGINITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALENDRONATE SODIUM AND CHOLECALCIFEROL 51 0.0184
1 PASIREOTIDE 16 0.0071
2 CEFACLOR 6 0.0039
3 PYRIDOXINE HYDROCHLORIDE 10 0.0037
4 CABERGOLINE 18 0.0037
5 NICOTINAMIDE 8 0.0031
6 TAMOXIFEN CITRATE 12 0.0021
7 ALENDRONATE SODIUM 176 0.0017
8 NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE 10 0.0017
9 ERGOCALCIFEROL 48 0.0016
See all drugs enriched for association with ATROPHIC VULVOVAGINITIS

ATROPHIC VULVOVAGINITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 18 0.0037
1 Guanylate Cyclase-C Agonist [EPC] 4 0.0019
2 Provitamin D2 Compound [EPC] 48 0.0016
3 Estrogen Agonist/Antagonist [EPC] 4 0.0015
4 Somatostatin Analog [EPC] 10 0.0015
5 Endoglycosidase [EPC] 2 0.0011
6 Methylating Agent [EPC] 1 0.0010
7 Nitrofuran Antibacterial [EPC] 15 0.0009
8 Estrogen [EPC] 156 0.0008
9 Vesicular Monoamine Transporter 2 Inhibitor [EPC] 1 0.0008
See all drug classes enriched for association with ATROPHIC VULVOVAGINITIS